At the end of 2017, a group of industrial veterans and scientists with decades of experience in drug research and development established Accro Bioscience (Suzhou) Limited. Wholly owned by Accro Bioscience (HK) Limited, Accro Bioscience (Suzhou) Limited is a clinical-stage biotech company with a core focus on molecular mechanisms of regulated cell death and related pathogenesis in human diseases. Through harnessing the power o...
At the end of 2017, a group of industrial veterans and scientists with decades of experience in drug research and development established Accro Bioscience (Suzhou) Limited. Wholly owned by Accro Bioscience (HK) Limited, Accro Bioscience (Suzhou) Limited is a clinical-stage biotech company with a core focus on molecular mechanisms of regulated cell death and related pathogenesis in human diseases. Through harnessing the power of science and drug discovery, the Company has developed a robust portfolio with innovative compounds in various stages spanning from lead optimization to clinical trials.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.